Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 1/2015

01-01-2015 | Original Article

Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience

Authors: Yves Dittmar, Silke Schüle, Alexander Koch, Falk Rauchfuss, Hubert Scheuerlein, Utz Settmacher

Published in: Langenbeck's Archives of Surgery | Issue 1/2015

Login to get access

Abstract

Purpose

Gastric cancer is a common disease with poor prognosis. Lymph node involvement is the strongest prognostic factor regarding survival in curatively (R0) resected patients. The aim of this study was to determine if a subgroup with higher risk for tumour recurrence exists in patients with node-negative gastric cancer. Furthermore, we aimed to identify prognostic factors and recurrence patterns for this subgroup.

Methods

We collected demographical, clinical, pathohistological and follow-up data from 1,074 patients with gastric cancer in a prospectively maintained database. In 228 cases, R0 resections for node-negative gastric cancer were performed. The median follow-up period was 59 months. Statistical analysis was performed using SPSS 19.0.

Results

The 5- , 10- and 15-year overall survival was 83, 75.5 and 73 %, respectively, with a disease-free survival of 78, 73 and 73 %. Tumour recurrence was observed in 18.9 % (43 cases), 14 % of which were diagnosed after more than 5 years. Gender, T-category , lymphangioinvasion, tumour differentiation, serosal infiltration, histological growth pattern, tumour size and classification according to Lauren were significant prognostic factors for overall survival in univariate analysis. Multivariate analysis showed tumour size and female sex to be independent prognostic factors. Non-exophytic tumour growth was a relevant factor for the development of local recurrence. Diffuse type gastric cancers as well as signet ring cells were significantly associated with the development of peritoneal carcinomatosis, and male gender with hematogenous metastases.

Conclusions

Multimodal treatment and individual follow-up might be beneficial in patients with higher risk of recurrence after R0 resection of node-negative gastric cancer.
Literature
1.
go back to reference Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer S (2004) Cancer statistics. CA Cancer J Clin 54(1):8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer S (2004) Cancer statistics. CA Cancer J Clin 54(1):8–29PubMedCrossRef
2.
go back to reference Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2(2):98–107PubMedCrossRef Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2(2):98–107PubMedCrossRef
3.
go back to reference Shukla PJ, Pavoor RSK, Barreto GS (2008) Gastric cancer in Europe (Br J Surg 2008; 95: 406-408 ). Br J Surg 95 (9) :1189; author reply 1189 Shukla PJ, Pavoor RSK, Barreto GS (2008) Gastric cancer in Europe (Br J Surg 2008; 95: 406-408 ). Br J Surg 95 (9) :1189; author reply 1189
4.
go back to reference Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228(4):449–461PubMedCentralPubMedCrossRef Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228(4):449–461PubMedCentralPubMedCrossRef
5.
go back to reference Liu X, Cai H, Shi Y, Wang Y (2012) Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg 16(6):1123–1127PubMedCrossRef Liu X, Cai H, Shi Y, Wang Y (2012) Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg 16(6):1123–1127PubMedCrossRef
6.
go back to reference Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, Rosa F, Marchet A, Coniglio A, Saragoni L, Veltri M, Pacelli F, Roviello F, Nitti D, Giulini SM, De Manzoni G (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252(1):70–73PubMedCrossRef Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, Rosa F, Marchet A, Coniglio A, Saragoni L, Veltri M, Pacelli F, Roviello F, Nitti D, Giulini SM, De Manzoni G (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252(1):70–73PubMedCrossRef
7.
go back to reference Sun P, Xiang JB, Chen ZY (2009) Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 96(1):26–33PubMedCrossRef Sun P, Xiang JB, Chen ZY (2009) Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 96(1):26–33PubMedCrossRef
8.
go back to reference Meyer C, Lozac'h P, Rohr S, Topar P, Youssef C, French Association of S (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65(3):161–165PubMed Meyer C, Lozac'h P, Rohr S, Topar P, Youssef C, French Association of S (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65(3):161–165PubMed
9.
go back to reference Meyer L, Steinert R, Nowak L, Gellert K, Ludwig K, Saeger D, Gastinger I, Lippert H (2005) [Prospective multicenter trial of gastric cancer surgery—a contribution to clinical research on quality control].Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms—Ein Beitrag zur klinischen Versorgungsforschung. Zentralbl Chir 130(2):97–105PubMedCrossRef Meyer L, Steinert R, Nowak L, Gellert K, Ludwig K, Saeger D, Gastinger I, Lippert H (2005) [Prospective multicenter trial of gastric cancer surgery—a contribution to clinical research on quality control].Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms—Ein Beitrag zur klinischen Versorgungsforschung. Zentralbl Chir 130(2):97–105PubMedCrossRef
10.
go back to reference Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, Coburn NG (2012) Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 15(Suppl 1):S100–S107PubMedCrossRef Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, Coburn NG (2012) Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 15(Suppl 1):S100–S107PubMedCrossRef
11.
go back to reference Dittmar Y, Rauchfuss F, Gotz M, Scheuerlein H, Jandt K, Settmacher U (2012) Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer. World J Surg 36(2):338–345PubMedCrossRef Dittmar Y, Rauchfuss F, Gotz M, Scheuerlein H, Jandt K, Settmacher U (2012) Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer. World J Surg 36(2):338–345PubMedCrossRef
12.
go back to reference Tamura S, Takeno A, Miki H (2011) Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol 2011:748745PubMedCentralPubMed Tamura S, Takeno A, Miki H (2011) Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol 2011:748745PubMedCentralPubMed
13.
go back to reference Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Surg Coop Group Lancet 347(9007):995–999 Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Surg Coop Group Lancet 347(9007):995–999
14.
go back to reference Songun I, Putter H, Kranenbarg EM-K , Sasako M, van de Velde CJH (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449PubMedCrossRef Songun I, Putter H, Kranenbarg EM-K , Sasako M, van de Velde CJH (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449PubMedCrossRef
15.
go back to reference Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surg Coop Group Br J Cancer 79(9–10):1522–1530CrossRef Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surg Coop Group Br J Cancer 79(9–10):1522–1530CrossRef
16.
go back to reference Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, Bechi P, Cortesini C (2000) Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol 74(1):30–32PubMedCrossRef Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, Bechi P, Cortesini C (2000) Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol 74(1):30–32PubMedCrossRef
17.
go back to reference Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H (1999) Significant prognostic factors in patients with node-negative gastric cancer. Int Surg 84(4):331–336PubMed Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H (1999) Significant prognostic factors in patients with node-negative gastric cancer. Int Surg 84(4):331–336PubMed
18.
go back to reference Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K (1997) Surgical treatment and outcome for node-negative gastric cancer. Surgery 121(6):633–639PubMedCrossRef Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K (1997) Surgical treatment and outcome for node-negative gastric cancer. Surgery 121(6):633–639PubMedCrossRef
19.
go back to reference Huang C-M , Lin J-X , Zheng C-H , Li P, Xie J-W , Lin B-J , Lu H-S (2009) Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol 15(31):3926–3930PubMedCentralPubMedCrossRef Huang C-M , Lin J-X , Zheng C-H , Li P, Xie J-W , Lin B-J , Lu H-S (2009) Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol 15(31):3926–3930PubMedCentralPubMedCrossRef
20.
go back to reference Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X (2008) Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 22(10):835–839PubMedCentralPubMed Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X (2008) Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 22(10):835–839PubMedCentralPubMed
21.
go back to reference Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101(7):622–625PubMedCrossRef Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101(7):622–625PubMedCrossRef
22.
go back to reference Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, Leal Ghezzi T, Rotmensz N, Bagnardi V, Andreoni B (2011) Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol 37(4):305–311PubMedCrossRef Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, Leal Ghezzi T, Rotmensz N, Bagnardi V, Andreoni B (2011) Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol 37(4):305–311PubMedCrossRef
23.
go back to reference Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237(6):828–835, discussion 835-827 PubMedCentralPubMed Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237(6):828–835, discussion 835-827 PubMedCentralPubMed
24.
go back to reference Seshadri RA, Jayanand SB, Ranganathan R (2011) Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol 9:48PubMedCentralPubMedCrossRef Seshadri RA, Jayanand SB, Ranganathan R (2011) Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol 9:48PubMedCentralPubMedCrossRef
25.
go back to reference Lee IS, Yook JH, Kim TH, Kim HS, Kim KC, Oh ST, Kim BS (2013) Prognostic factors and recurrence pattern in node-negative advanced gastric cancer. Eur J Surg Oncol 39(2):136–140PubMedCrossRef Lee IS, Yook JH, Kim TH, Kim HS, Kim KC, Oh ST, Kim BS (2013) Prognostic factors and recurrence pattern in node-negative advanced gastric cancer. Eur J Surg Oncol 39(2):136–140PubMedCrossRef
26.
go back to reference Jeong JY, Kim MG, Ha TK, Kwon SJ (2012) Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer 12(4):210–216PubMedCentralPubMedCrossRef Jeong JY, Kim MG, Ha TK, Kwon SJ (2012) Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer 12(4):210–216PubMedCentralPubMedCrossRef
27.
go back to reference Wu H, Wang L, He Y-l, Xu J-B, Cai S-R, Ma J-P, Chen C-Q, Zhang X-H, Zhan W-H (2013) Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients. Zhonghua Zhong Liu Za Zhi 35(7):509–513PubMed Wu H, Wang L, He Y-l, Xu J-B, Cai S-R, Ma J-P, Chen C-Q, Zhang X-H, Zhan W-H (2013) Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients. Zhonghua Zhong Liu Za Zhi 35(7):509–513PubMed
28.
go back to reference Ryo WS, Kim JH, Yang YJ, Park SS, Um JW, Park SH, Kim SJ, Mok YJ, Kim CS (2012) Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol 106(4):456–461CrossRef Ryo WS, Kim JH, Yang YJ, Park SS, Um JW, Park SH, Kim SJ, Mok YJ, Kim CS (2012) Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol 106(4):456–461CrossRef
29.
go back to reference Ke B, Liu N, Liang H, Zhang R-P, Wang X-J, Wu L-L (2011) Prognostic factors in 138 patients with node-negative gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 14(3):192–195PubMed Ke B, Liu N, Liang H, Zhang R-P, Wang X-J, Wu L-L (2011) Prognostic factors in 138 patients with node-negative gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 14(3):192–195PubMed
30.
go back to reference Lee C-C, Wu C-W, Lo S-S, Chen J-H, Li AFY, Hsieh M-C, Shen K-H, Lui W-Y (2007) Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol 22(7):1014–1018PubMedCrossRef Lee C-C, Wu C-W, Lo S-S, Chen J-H, Li AFY, Hsieh M-C, Shen K-H, Lui W-Y (2007) Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol 22(7):1014–1018PubMedCrossRef
31.
go back to reference Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E (2009) Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol 100(2):111–114PubMedCrossRef Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E (2009) Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol 100(2):111–114PubMedCrossRef
32.
go back to reference Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani P (2004) Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 35(3):357–366PubMedCrossRef Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani P (2004) Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 35(3):357–366PubMedCrossRef
33.
go back to reference Koperek O, Scheuba C, Puri C, Birner P, Haslinger C, Rettig W, Niederle B, Kaserer K, Garin Chesa P (2007) Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol 31(1):59–67PubMed Koperek O, Scheuba C, Puri C, Birner P, Haslinger C, Rettig W, Niederle B, Kaserer K, Garin Chesa P (2007) Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol 31(1):59–67PubMed
34.
go back to reference Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y (2012) Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 7(6):e38681PubMedCentralPubMedCrossRef Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y (2012) Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 7(6):e38681PubMedCentralPubMedCrossRef
35.
go back to reference Kim J-H, Park J-M, Jung C-W, Park S-S, Kim S-J, Mok Y-J, Kim C-S, Chae Y-S, Bae J-W (2008) The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 97(2):125–130PubMedCrossRef Kim J-H, Park J-M, Jung C-W, Park S-S, Kim S-J, Mok Y-J, Kim C-S, Chae Y-S, Bae J-W (2008) The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 97(2):125–130PubMedCrossRef
36.
go back to reference Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP (2008) Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112(6):1239–1246PubMedCrossRef Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP (2008) Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112(6):1239–1246PubMedCrossRef
37.
go back to reference Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312(25):1604–1608PubMedCrossRef Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312(25):1604–1608PubMedCrossRef
38.
go back to reference Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1):1–11PubMedCrossRef Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1):1–11PubMedCrossRef
39.
go back to reference Motoori M, Takemasa I, Yano M, Saito S, Miyata H, Takiguchi S, Fujiwara Y, Yasuda T, Doki Y, Kurokawa Y, Ueno N, Oba S, Ishii S, Monden M, Kato K (2005) Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer 114(6):963–968PubMedCrossRef Motoori M, Takemasa I, Yano M, Saito S, Miyata H, Takiguchi S, Fujiwara Y, Yasuda T, Doki Y, Kurokawa Y, Ueno N, Oba S, Ishii S, Monden M, Kato K (2005) Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer 114(6):963–968PubMedCrossRef
40.
go back to reference Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, Kim YJ, Kim SK (2006) Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 12(8):1182–1186PubMedCentralPubMed Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, Kim YJ, Kim SK (2006) Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 12(8):1182–1186PubMedCentralPubMed
Metadata
Title
Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience
Authors
Yves Dittmar
Silke Schüle
Alexander Koch
Falk Rauchfuss
Hubert Scheuerlein
Utz Settmacher
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 1/2015
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-014-1226-2

Other articles of this Issue 1/2015

Langenbeck's Archives of Surgery 1/2015 Go to the issue